Dexibuprofen

CHEMBL175 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
206.3 g/mol
LogP
3.5
Phase
4

The pharmacologically active S-enantiomer of ibuprofen, used to treat pain and inflammation in conditions such as arthritis, menstrual pain, and headache. It provides the same anti-inflammatory and analgesic effects as racemic ibuprofen but at a lower dose. Its gastrointestinal side effect profile is similar to standard ibuprofen.

Khối lượng phân tử

206,2800 g/mol

LogP

3,50

TPSA

37,30 Ų

Lipinski RO5

Đạt

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)Cc1ccc([C@H](C)C(=O)O)cc1

InChI

InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1

Molecular Formula

C13H18O2

HBD / HBA

1 / 2

Liên kết có thể quay

4

Nguyên tử nặng

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

The pharmacologically active S-enantiomer of ibuprofen, used to treat pain and inflammation in conditions such as arthritis, menstrual pain, and headache. It provides the same anti-inflammatory and analgesic effects as racemic ibuprofen but at a lower dose. Its gastrointestinal side effect profile is similar to standard ibuprofen.

Yes, Dexibuprofen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL175. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 39912. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.